Inflammatory bowel disease essentials. Dr. Jeremy Sanderson Guy s & St. Thomas Hospitals
|
|
- Elwin Rose
- 7 years ago
- Views:
Transcription
1 Inflammatory bowel disease essentials Dr. Jeremy Sanderson Guy s & St. Thomas Hospitals
2 Inflammatory bowel disease(s) IBD Crohn s disease (CD) Ulcerative colitis (UC) + several other rarer types of IBD
3 Inflammatory bowel disease(s) IBD Chronic Relapsing / remitting Uncertain aetiology Significant negative QOL impact Relatively uncommon increasing? 2-3 cases per 1000 population GP practice of 20,000 : cases
4 Crohn s disease (CD) = mouth to anus Ulcerative colitis (UC) = colon only + extra-intestinal complications : joints, eyes, skin.
5 Aetiology of UC Early life exposure Early life exposure Microbiota diversity function pathogenicity Gut immunity Tolerance Innate immunity Environment Epithelial & mucus layer Integrity function Genetics
6 E.coli persistence in CD macrophages Benefit of intracellular antibiotics?
7 Negative QOL in IBD Nature of symptoms! Educational loss Occupational loss Reduced aspiration Social avoidance Relationship avoidance Care (Primary to tertiary) = Chronic disease management
8 What is best practice in IBD?
9
10
11 IBD standards Specialist IBD team 2 WTE IBD Gastroenterologists 2 WTE IBD Colorectal surgeons 1.5 WTE IBD Clinical Nurse Specialists 0.5 WTE CNS in stoma/pouch therapy 0.5 WTE Dietitian 0.5 WTE Admin support for IBD service 1 Named Gastro Histopathologist 1 Named Gastro Radiologist 1 Named Gastro Pharmacist IBD Multi-disciplinary meeting Medical Surgical interaction Arrangements for biologic and immunosuppressive treatment Arrangements for care of children and young adults with IBD Access to Nutritional support and therapy Arrangements for care of in-patients with IBD Arrangements for care of out-patients with IBD
12 Implementing IBD standards How do we do at GSTT??
13 IBD standards Specialist IBD team 2 WTE IBD Gastroenterologists 2 WTE IBD Colorectal surgeons 1.5 WTE IBD Clinical Nurse Specialists 0.5 WTE CNS in stoma/pouch therapy 0.5 WTE Dietitian 0.5 WTE Admin support for IBD service 1 Named Gastro Histopathologist 1 Named Gastro Radiologist 1 Named Gastro Pharmacist IBD Multi-disciplinary meeting Medical Surgical interaction Arrangements for biologic and immunosuppressive treatment Arrangements for care of children and young adults with IBD Access to Nutritional support and therapy Arrangements for care of in-patients with IBD Arrangements for care of out-patients with IBD
14 IBD standards Specialist IBD team 2 WTE IBD Gastroenterologists 2 WTE IBD Colorectal surgeons 1.5 WTE IBD Clinical Nurse Specialists 0.5 WTE CNS in stoma/pouch therapy 0.5 WTE Dietitian 0.5 WTE Admin support for IBD service 1 Named Gastro Histopathologist 1 Named Gastro Radiologist 1 Named Gastro Pharmacist IBD Multi-disciplinary meeting Arrangements for biologic and immunosuppressive treatment Access to Nutritional support and therapy Arrangements for care of out-patients with IBD
15 IBD standards Medical Surgical interaction Arrangements for care of children and young adults with IBD Arrangements for care of in-patients with IBD
16 IBD standards Primary : secondary / tertiary care interface in IBD? Key issues : Complex disease, low prevalence Patients want rapid access to advice re flares, questions GP s want / need rapid advice re the same Increasingly complicated treatment All secondary care? Shared care agreements for immunosuppression Key roles for IBD Nurse specialists and IBD pharmacists
17 IBDHELPLINE IBD PHONE
18 What is best practice in IBD?
19 Changing goals of therapy in IBD..mucosal healing feasible with more aggressive therapy = not using ineffective Rx = early use of azathioprine / mercaptopurine = greater use of biologics (eg anti-tnf agents)
20 Anti-TNFa antibody strategies for CD.... most important advance in IBD since corticosteroids
21 Efficacy of anti-tnf agents in Crohn s disease % SONIC Week 26: Corticosteroid-free clinical remission p=0.022 Out of trial experience.80% clinical benefit
22 Efficacy of anti-tnf agents in Crohn s disease Mucosal healing Therefore.. Reduced complications Reduced hospitalisation Reduced surgery Improved QOL
23 GSTT Specialist IBD service : CCG agreed treatment pathway Moderate severe UC Failing oral immunosuppression Golimumab Inflimxab / Adalimumab Clinical trial Vedolizumab
24 GSTT Specialist IBD service : CCG agreed treatment pathway Moderate severe CD Failing oral immunosuppression Inflimxab / Adalimumab Clinical trial Vedolizumab
25 All roads lead to a thiopurine? Mild CD Post-op CD Moderate CD Severe CD Mild Non-healing Rx 5-ASA Diet Antibiotics AZA / 6-MP Steroids Biologics
26 Personalised approach to IBD treatment.. Pharmacogenetics individual variation in the handling of drugs in the body according to genetically determined factors.
27 Adverse drug reactions (ADR) and hospital admissions 6.5% admissions due to ADR in 6 months In 80% of cases, median bed stay 8 days 4% of hospital bed capacity Overall fatality 0.15% Projected cost to NHS million pa Most ADR avoidable Pirmohamed et al, BMJ 3 July 2004
28 Zaza Gianluigi et al. "Thiopurine pathway" Pharmacogenetics and genomics (2009)
29 Old dogs..new tricks..
30 Biotransformation of 6-MP to thioguanine nucleotides imidazole 6-TU Immunosuppression Aza TPMT 6-MP Xanthine Oxidase TGNs Methyl metabolites Cytotoxicity
31 Polymorphic Trimodal distribution of TPMT activity Normal activity 90% 500 Frequency (no. patients) in 300 Zero activity 1 in 10 Intermediate activity Very high activity TPMT TPMT activity distribution in 5000 PRL samples, Sanderson et al ACB 2004
32 Biotransformation of 6-MP to thioguanine nucleotides Allopurinol imidazole 6-TU _ Immunosuppression Aza 6-MP Xanthine Oxidase TGNs _ TPMT? TPMT inhibitor Methyl metabolites Cytotoxicity
33 TGN monitoring in routine clinical practice: review of 190 patients on AZA for IBD High 29% Very low 6% Low 21% 10% preferential methylation [~60% non-response] Smith M UEGW 2009 Therapeutic 41%
34 AZA treatment?..before starting... IBD Check panel TPMT : TPMT + Enzyme ITPA, AOX,HLA-G, / genotype ABCB5 Homozygous deficient Heterozygous deficient Consider 5-10mg AZA or avoid AZA Alternative Rx Very high Normal Allopur 100mg + AZA 0.5mg/kg Initiate at 100mg Build to 2mg/kg 4 WEEK TGN level 4 MONTH 4mo TGN level Persuade to take! Increase, continue, decrease dose Switch to allo/aza Switch drug Duration of Rx?? Initiate at 25mg Build to 1mg/kg Nausea Flu-like illness Pancreatitis Hepatitis Myelosuppression Reduce dose Switch to 6-MP V slow escalation 6-MP, check ITPA Alternative Rx 6-TG, MTX, MMF Allopurinol + AZA Dose by TGNs Check dose Parvovirus, drugs etc
35 Can pharmacogenetics / TGN s achieve this? 10-20% more?? % success
36 Can pharmacogenetics / TGN s achieve this? % success YES TPMT AOX TGN Allo/AZA Calculation of opportunity from 6-MP switch individualised approach: Using 17% hypermethylation and 6-20% published side effect rates Opportunity for allopurinol / thiopurine = 12-24%
37 What has that got to do with me?? Earlier diagnosis is important Treatment before complications develop Issues for prescribing and monitoring More difficult to give advice (super-specialised) *** Treatment of flares of IBD ***
38 Case for discussion 29 year old female lawyer Known to have ulcerative colitis 4 years c/o rectal bleeding with mucus, urgency, 6-7x day 3 weeks Sometimes normal stool Feels tired but working Stressed Stopped smoking one month ago No FH of IBD
39 Question : Which missing information do you need to guide your decision on initial treatment? 1.Details of the type of IBD and distribution? 2.Current therapy for IBD? 3.Currently pregnant? 4.Travel History? 5.All of the above?
40 Managing a flare of IBD What type of IBD Crohn s or UC? Which site or pattern of IBD? Distal UC vs pnacolitis Ileal vs colonic CD How severe? Mild/mod/severe. What is the current treatment? None? Mesalazine? Steroids? Could it be intercurrent infection? Travel? Others ill.. Is there a plan for flare up agreed with IBD clinic?
41 Managing a flare of UC Consider infection history, stool mcs + / - Blood tests FBC, biochem, CRP (not essential to Rx) Faecal calptotectin Sigmoidoscopy / colonoscopy - consider if uncertainty regarding diagnosis - concern re nature of symtpoms
42 Managing a flare of UC Mesalazine at active disease dose Eg Pentasa 4g daily, Asacol 2.4g daily Mezavant 2.4g Proctiits use suppository 1g mesalazine Left sided consider addition of 1g foam or liquid enema If already on mesalazine, consider high dose (8g / 4.8g) THEN..consider steroid Prednisolone 20mg daily 2 weeks in moderate Prednisolone 40mg reducing course in mod-severe
43 5-ASA for proctitis and proctosigmoiditis Rectal 5-ASA >> rectal steroid Rectal 5-ASA > oral 5-ASA Rectal and oral even better
44 Case history.. Stool culture pending (subsequently negative) Consultant letters indicate proctitis (distal UC) Currently on Asacol 1.2g daily Decision to increase to 2.4g daily and add 1g suppository 5-ASA Hold off steroids Says 7 weeks pregnant does it matter?
45 Managing a flare of Crohn s Consider infection history, stool mcs Assess severity mild / mod / severe Is it an obstructive episode? Mesalazine is NOT an effective drug in Crohn s Antibiotics are a GOOD option for temporary treatment ileal or colonic Ciprofloxacin 500mg bd or Metronidazole 400mg tds THEN..consider steroid Prednisolone 20mg daily 2 weeks in moderate Prednilonone 40mg reducing course in mod-severe Obstructive episodes may settle with liquid diet but consider admission
46 IBDHELPLINE IBD PHONE
47 IBD essentials Key points Complex chronic conditions Uncommon but not rare Significant QOL impairment Treatments increasingly specialized but successful IBD standards have helped to drive quality of care Primary / secondary / tertiary care interface very important Access to prompt specialist advice critical Knowledge of managing certain aspects in primary care important
EVIDENCE BASED TREATMENT OF CROHN S DISEASE. Dr E Ndabaneze
EVIDENCE BASED TREATMENT OF CROHN S DISEASE Dr E Ndabaneze PLAN 1. Case presentation 2. Topic on Evidence based Treatment of Crohn s disease - Introduction pathology aetiology - Treatment - concept of
More informationMedical Therapy for IBD
CHILDREN S DIGESTIVE HEALTH & NUTRITION FOUNDATION NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION Medical Therapy for IBD I. INTRODUCTION The treatment of Crohn s disease
More informationUnderstanding Colitis and Crohn s Disease
Improving life for people affected by Colitis and Crohn s Disease Understanding Colitis and Crohn s Disease 1 Understanding Colitis and Crohn s Disease Understanding Ulcerative Colitis and Crohn s Disease...
More informationTREATING INFLAMMATORY BOWEL DISEASE (IBD) BACKGROUNDER
Press information for journalists only TREATING INFLAMMATORY BOWEL DISEASE (IBD) BACKGROUNDER Why treat IBD? IBD describes a range of chronic diseases of the gastrointestinal system, encompassing Ulcerative
More informationUlcerative Colitis & Proctitis. About Ulcerative Colitis & Proctitis
Ulcerative Colitis & Proctitis About Ulcerative Colitis & Proctitis When you first learn that you have ulcerative colitis, you will probably feel overwhelmed. You may not even have heard of ulcerative
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Multiple Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Multiple Technology Appraisal Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional
More informationadult services between 1 January and 31 December 2013 had an operation where the
Organisational audit: round 4 Adult services audit tool Section 1: Demographics DEM 1.1 How many IBD patients does your service manage? DEM 1.2 Is this figure: an estimate (enter e ) or from a database/register
More informationThe Oxford IBD Service
Gastroenterology Unit, John Radcliffe Hospital The Oxford IBD Service Information for patients Information for patients 1 The Oxford Inflammatory Bowel Disease (IBD) Service Consultant Gastroenterologists
More informationColon and Rectal Cancer
Colon and Rectal Cancer What is colon or rectal cancer? Colon or rectal cancer is the growth of abnormal cells in your large intestine, which is also called the large bowel. The colon is the last 5 feet
More information11/10/2014. New Treatments in IBD: When, Whom and How. Background. Background. Options. Disease Assessment. What is the evidence?
New Treatments in IBD: When, Whom and How. Background Options Disease Assessment What is the evidence? Kofi Clarke MD, FACP,FRCP (Lond) Clinical Associate Professor, Chief, Gastroenterology, Hepatology
More informationTop Down vs. Step Up Therapy Biologics in IBD: Treatment Algorithms. Stephen B. Hanauer, M.D. University of Chicago
Top Down vs. Step Up Therapy Biologics in IBD: Treatment Algorithms Stephen B. Hanauer, M.D. University of Chicago Treatment Goals c.2008 Induce and maintain response/remission Prevent complications Disease
More informationPREPARING FOR YOUR STOMA REVERSAL
PREPARING FOR YOUR STOMA REVERSAL Information Leaflet Your Health. Our Priority. Page 2 of 6 Introduction- What you need to know As part of your bowel operation you may have had a temporary stoma formed.
More informationOriginal Policy Date
MP 5.01.20 Tysabri (natalizumab) Medical Policy Section Prescription Drug Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Local Policy/12:2013 Return to Medical Policy Index Disclaimer
More informationGuidelines for the management of inflammatory bowel disease in adults
v1 GUIDELINES Guidelines for the management of inflammatory bowel disease in adults M J Carter, A J Lobo, S P L Travis, on behalf of the IBD Section of the British Society of Gastroenterology... Gut 2004;53(Suppl
More informationDecision systems in quality registries
Decision systems in quality registries Stockholm Dec 9 th, 2014 Jonas Halfvarson, MD, PhD Dept of Gastronterology, Faculty of Medicine and Health, Örebro University 1 Quality registries for chronic diseases
More informationBiologic Treatments for Rheumatoid Arthritis
Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been
More informationEvidence of Crohn s Disease. Case Presentation
Witt Wait to Treat tutiled Until Endoscopic Evidence of Crohn s Disease Raymond Cross, MD, MS, AGAF Associate Professor of Medicine Director, IBD Program University of Maryland School of Medicine Co-Director,
More informationLeukapheresis for inflammatory bowel disease
Issue date: June 2005 Leukapheresis for inflammatory bowel disease Understanding NICE guidance information for people considering the procedure, and for the public Information about NICE Interventional
More informationUlcerative Colitis. National Digestive Diseases Information Clearinghouse. What is ulcerative colitis (UC)?
Ulcerative Colitis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is ulcerative colitis (UC)? Ulcerative colitis is
More informationHow long will it take to work? You may begin to feel better within a few days or it may take up to six weeks after your first treatment session.
Crohn's and Colitis UK Drug Treatment Information Improving life for people affected by inflammatory bowel diseases Infliximab This information leaflet aims to answer common questions you may have if you
More informationLaparoscopic Colectomy. What do I need to know about my laparoscopic colorectal surgery?
Laparoscopic Colectomy What do I need to know about my laparoscopic colorectal surgery? Traditionally, colon & rectal surgery requires a large, abdominal and/or pelvic incision, which often requires a
More informationCrohn's disease and ulcerative colitis
Crohn's disease and ulcerative colitis Summary Crohn s disease and ulcerative colitis are collectively known as inflammatory bowel disease (IBD). Crohn s disease can appear in any part of a person s digestive
More informationCrohn s Disease. What is Crohn s Disease? ho gets Crohn s Disease? hat are the symptoms? What causes Crohn s Disease?
In association with: Primary Care Society for Gastroenterology INFORMATION ABOUT Crohn s Disease What is Crohn s Disease? ho gets Crohn s Disease? What causes Crohn s Disease? hat does it do to the intestine?
More informationComplications that may occur with ulcerative colitis:
Ulcerative Colitis What is ulcerative colitis? Ulcerative colitis is one of the major forms of inflammatory bowel disease. The other major form is Crohn s disease. Ulcerative colitis is felt to be due
More informationArthritis and Rheumatology Clinics of Kansas Patient Education. Reactive Arthritis (ReA) / Inflammatory Bowel Disease (IBD) Arthritis
Arthritis and Rheumatology Clinics of Kansas Patient Education Reactive Arthritis (ReA) / Inflammatory Bowel Disease (IBD) Arthritis Introduction: For as long as scientists have studied rheumatic disease,
More informationInflammatory Bowel Disease. (Ulcerative Colitis and Crohn s Disease)
Ministry of Defence Synopsis of Causation Inflammatory Bowel Disease (Ulcerative Colitis and Crohn s Disease) Authors: Dr Hazel Younger, Ninewells Hospital and Medical School, Dundee and Dr Craig Mowat,
More informationRELAPSE MANAGEMENT. Pauline Shaw MS Nurse Specialist 25 th June 2010
RELAPSE MANAGEMENT Pauline Shaw MS Nurse Specialist 25 th June 2010 AIMS OF SESSION Relapsing/Remitting MS Definition of relapse/relapse rate Relapse Management NICE Guidelines Regional Clinical Guidelines
More informationProposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine
Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine Contents Mission... 1 Background... 2 Services and Programs... 2 Clinical Care... 2 IBD Specialists...
More informationOpportunistic Infections Related to Immune Suppressant and Biologic Drug Therapy in IBD
Opportunistic Infections Related to Immune Suppressant and Biologic Drug Therapy in IBD Raymond Cross, M.D., M.S., AGAF Associate Professor of Medicine Director of the Inflammatory Bowel Disease Program
More informationINFLAMMATORY BOWEL DISEASE (IBD) MEASURES GROUP OVERVIEW
SPECIFICATION F MEASURES GROUP REPTING ONLY INFLAMMATY BOWEL DISEASE (IBD) MEASURES GROUP OVERVIEW 2012 PHYSICIAN QUALITY REPTING OPTIONS F MEASURES GROUPS: REGISTRY ONLY 2012 PHYSICIAN QUALITY REPTING
More informationBriefing Document. Food and Drug Administration. Center for Drug Evaluation and Research
Briefing Document Food and Drug Administration Center for Drug Evaluation and Research Meeting: Joint Meeting of the Gastrointestinal Drugs Advisory Committee (GIDAC) and the Drug Safety and Risk Management
More informationAntibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis
Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis ANTIBIOTIC-ASSOCIATED DIARRHEA Disturbance of the normal colonic microflora Leading to alterations in bacterial degradation
More informationUlcerative Colitis. National Digestive Diseases Information Clearinghouse
Ulcerative Colitis National Digestive Diseases Information Clearinghouse What is ulcerative colitis? Ulcerative colitis is a chronic, or long lasting, disease that causes inflammation irritation or swelling
More informationProbiotics for the Treatment of Adult Gastrointestinal Disorders
Probiotics for the Treatment of Adult Gastrointestinal Disorders Darren M. Brenner, M.D. Division of Gastroenterology Northwestern University, Feinberg School of Medicine Chicago, Illinois What are Probiotics?
More informationRheumatoid Arthritis monitoring of DMARDs
www.bpac.org.nz keyword: DMARDS Rheumatoid Arthritis monitoring of DMARDs Key reviewers: Professor John Highton, Head of Section, Department of Medical and Surgical Sciences, Dunedin School of Medicine,
More informationLawyers / Attorneys: Evaluation of Nationwide Accutane Accidents, Injuries & Death
The Fox Law Firm is Reviewing Potential ACCUTANE Claims. In the United States, jury trials have awarded at least $33 million dollars to patients as compensation for injuries attributed to Accutane use.
More informationLiving with Ulcerative Colitis
Living with Ulcerative Colitis What s Inside? Understanding the diagnosis 1 What is ulcerative colitis? 2 Will it ever go away? 3 A brief introduction to the 3 gastrointestinal (GI) tract Who gets ulcerative
More informationIntravenous Methyl Prednisolone in Multiple Sclerosis
Intravenous Methyl Prednisolone in Multiple Sclerosis Exceptional healthcare, personally delivered Relapse management in multiple sclerosis Relapses in multiple sclerosis (MS) are common and caused by
More informationAllopurinol Allopurinol
Drug information Allopurinol Allopurinol This leaflet provides information on allopurinol and will answer any questions you have about the treatment. Arthritis Research UK produce and print our booklets
More informationBile Duct Diseases and Problems
Bile Duct Diseases and Problems Introduction A bile duct is a tube that carries bile between the liver and gallbladder and the intestine. Bile is a substance made by the liver that helps with digestion.
More informationCrohn s Disease. What I need to know about. U.S. Department of Health and Human Services
What I need to know about Crohn s Disease NATIONAL INSTITUTES OF HEALTH National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services What I need to know about Crohn
More informationUlcerative Colitis. Living with
Living with Ulcerative Colitis Our Mission: To cure and prevent Crohn s disease and ulcerative colitis through research, and to improve the quality of life of children and adults affected by these digestive
More informationCrohn s and Colitis Foundation of Canada / Vertex Pharmaceuticals. Sponsored Research Program in Inflammatory Bowel Disease
Crohn s and Colitis Foundation of Canada / Vertex Pharmaceuticals Sponsored Research Program in Inflammatory Bowel Disease Presentation Overview Background on inflammatory bowel disease Partner Overview
More informationPHARMACOLOGIC MANAGEMENT FOR INFLAMMATORY BOWEL DISEASE: ULCERATIVE COLITIS & CROHN S DISEASE
PHARMACOLOGIC MANAGEMENT FOR INFLAMMATORY BOWEL DISEASE: ULCERATIVE COLITIS & CROHN S DISEASE Joseph Reilly, B.S., Pharm.D. Residency Program Director / Clinical Specialist AtlantiCare Regional Medical
More informationTerapia con farmaci biologici e non nella. Sandro Ardizzone. Azienda Ospedaliera Fatebenefratelli e. Ospedale di Rilievo Nazionale Milan
Terapia con farmaci biologici e non nella Colite Ulcerosa Severa/Refrattaria Sandro Ardizzone Gastrointestinal Unit Azienda Ospedaliera Fatebenefratelli e Oftalmico Ospedale di Rilievo Nazionale Milan
More informationMY CROHN S AND COLITIS CARE YOUR GUIDE
MY CROHN S AND COLITIS CARE YOUR GUIDE Sometimes living with IBD is frustrating but having the right information and support has helped me to feel more in control of my life. Melissa, 44 Diagnosed with
More informationWhat Is Clostridium Difficile (C. Diff)? CLOSTRIDIUM DIFFICILE (C. DIFF)
What Is Clostridium Difficile (C. Diff)? Clostridium difficile, or C. diff for short, is an infection from a bacterium, or bug, that can grow in your intestines and cause bad GI symptoms. The main risk
More informationSummary of the risk management plan (RMP) for Orkambi (lumacaftor and ivacaftor)
EMA/662624/2015 Summary of the risk management plan (RMP) for Orkambi (lumacaftor and ivacaftor) This is a summary of the risk management plan (RMP) for Orkambi, which details the measures to be taken
More informationAn Overview of the Management of Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS) Sue Surgenor October 6 th 2015
An Overview of the Management of Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS) Sue Surgenor October 6 th 2015 Background Teasing out the differential Reviewing treatment options Personalised
More informationhttp://www.rxabbvie.com/pdf/humira.pdf (accessed 4/23/15)
Novel Treatment of Inflammatory Bowel Disease Informed by Science and Patient Choice Unanswered Questions March 11, 2015 Russell D. Cohen, MD, FACG, AGAF Medical marijuana in IBD 1. Unfortunately, with
More informationSecondary liver cancer Patient Information Booklet
Secondary liver cancer Patient Information Booklet Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationAdult Inflammatory Bowel Disease Physician Performance Measures Set. August 2011*
Adult Inflammatory Bowel Disease Physician Performance Measures Set August 2011* *Last revised on October 26, 2011 American Gastroenterological Association Adult Inflammatory Bowel Disease Physician Performance
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE DEVELOPMENT OF NEW MEDICINAL PRODUCTS FOR THE TREATMENT OF ULCERATIVE COLITIS
European Medicines Agency London, 24 January 2008 Doc. Ref. CHMP/EWP/18463/2006 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE DEVELOPMENT OF NEW MEDICINAL PRODUCTS FOR THE TREATMENT
More informationManaging Flares. and Other IBD Symptoms. Information Resource Center (888.694.8872)
Managing Flares and Other IBD Symptoms Information Resource Center 888.MY.GUT.PAIN (888.694.8872) www.ccfa.org What s Inside? What is a flare? 3 What can cause a flare? 5 Flares from ulcerative colitis
More informationCeliac Disease. Donald Schoch, M.D. Ohio ACP Meeting October 17, 2014
Celiac Disease Donald Schoch, M.D. Ohio ACP Meeting October 17, 2014 None to disclose Conflicts of Interest Format Present a case Do a pretest about the evaluation Review case Discuss the questions & answers
More informationCrohn's and Colitis UK Information Sheet. Students with IBD: a guide for universities and colleges
Crohn's and Colitis UK Information Sheet Improving life for people affected by inflammatory bowel diseases Students with IBD: a guide for universities and colleges Introduction It is very likely that several
More informationRheumatoid Arthritis. GP workshop 15 January 2011
Rheumatoid Arthritis GP workshop 15 January 2011 Case 1 A 72 year old Malay woman with RA comes for routine follow up. She feels generally unwell in the last 5 days. Appetite is fair. Her joints are fine.
More informationWhat are the Unmet Needs in the Management of IBD?
23/6/214 What are the Unmet Needs in the Management of IBD? Shane Devlin, MD, FRCPC Inflammatory Bowel Disease Group The University of Calgary Some Real Cases: #1 32 yo male with pan UC. Grumbling phenotype
More informationColonic Stenting Your Procedure Explained
Colonic Stenting Your Procedure Explained Patient Information Introduction This leaflet tells you about the procedure known as colonic stenting. It explains what is involved and some of the common complications
More informationColonoscopy Data Collection Form
Identifier: Sociodemographic Information Type: Zip Code: Gender: Height: (inches) Race: Ethnicity Inpatient Outpatient Male Female Birth Date: Weight: (pounds) American Indian (Native American) or Alaska
More informationNational audit of inflammatory bowel disease (IBD) service provision
National audit of inflammatory bowel disease (IBD) service provision UK IBD audit National report September 2014 Prepared by the Clinical Effectiveness and Evaluation Unit at the Royal College of Physicians
More informationColorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society
Colorectal Cancer: Preventable, Beatable, Treatable American Cancer Society Reviewed January 2013 What we ll be talking about How common is colorectal cancer? What is colorectal cancer? What causes it?
More informationFastTest. You ve read the book... ... now test yourself
FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. Please refer back to relevant sections
More informationNew onset diabetes after transplant (NODAT)
New onset diabetes after transplant (NODAT) Information for families Great Ormond Street Hospital for Children NHS Foundation Trust This information sheet from Great Ormond Street Hospital (GOSH) explains
More informationInguinal Hernia (Female)
Inguinal Hernia (Female) WHAT IS AN INGUINAL HERNIA? 2 WHAT CAUSES AN INGUINAL HERNIA? 2 WHAT DOES TREATMENT / MANAGEMENT INVOLVE? 3 DAY SURGERY MANAGEMENT 3 SURGICAL REPAIR 4 WHAT ARE THE RISKS/COMPLICATIONS
More informationDevelop an understanding of the differential diagnosis of pseudomembranous colitis
Update on Clostridium difficile Colitis Clostridium difficile infection has recently emerged in populations without any known risk factors. This presentation will focus on the historical background, diagnosis,
More informationLaparoscopic Surgery of the Colon and Rectum (Large Intestine) A Simple Guide to Help Answer Your Questions
Laparoscopic Surgery of the Colon and Rectum (Large Intestine) A Simple Guide to Help Answer Your Questions What are the Colon and Rectum? The colon and rectum together make up the large intestine. After
More informationNHS FORTH VALLEY Multiple Sclerosis Service Management of MS Relapses
NHS FORTH VALLEY Multiple Sclerosis Service Management of MS Relapses Approved 22/06/2010 Version Version 2 Date of First Issue 2002 Review Date 10/05/2016 Date of Issue 01/02/2010 EQIA Yes 22.06.10 Author
More informationIn vitro co-culture model of the inflamed intestinal mucosa
In vitro co-culture model of the inflamed intestinal mucosa Berlin, December 13, 2011 Eva-Maria Collnot, e.collnot@mx.uni-saarland.de Helmholtz Institute for Pharmaceutical Research Saarland Departement
More informationCrohn s and Colitis Center
Crohn s and Colitis Center Dedicated to caring for patients with inflammatory bowel disease Crohn s disease and ulcerative colitis. The Crohn s and Colitis Center is the only center in New England exclusively
More informationColorectal Cancer Care A Cancer Care Map for Patients
Colorectal Cancer Care A Cancer Care Map for Patients Understanding the process of care that a patient goes through in the diagnosis and treatment of colorectal cancer in BC. Colorectal Cancer Care Map
More informationChoosing Outcome Measures in Pediatric IBD. Anne M Griffiths, MD Hospital for Sick Children University of Toronto Toronto, Canada
Choosing Outcome Measures in Pediatric IBD Anne M Griffiths, MD Hospital for Sick Children University of Toronto Toronto, Canada Disclosures The content of this presentation reflect my personal opinions
More informationHere is a broad, but certainly not complete list of options for patients to consider when developing a plan to take charge of their IBD treatment:
OLDER ADULTS AND IBD Inflammatory bowel diseases (IBD), such as Crohn s disease and ulcerative colitis, are traditionally diagnosed in younger people. However, the fact that they are life-long diseases
More informationQS114. NICE quality standard for irritable bowel syndrome in adults (QS114)
NICE quality standard for irritable bowel syndrome in adults (QS114) QS114 NICE approved the reproduction of its content for this booklet. The production of this booklet is sponsored by Thermo Fisher Scientific,
More informationThis fact sheet was adapted from www.cancerinsurancechecklist.org
IBD Insurance Checklist How This Checklist Can Help You The IBD Insurance Checklist is designed to help you compare insurance plans and consider your health needs when shopping for insurance in the Health
More informationNHS. Percutaneous endoscopic colostomy. National Institute for Health and Clinical Excellence. Issue date: March 2006
NHS National Institute for Health and Clinical Excellence Issue date: March 2006 Percutaneous endoscopic colostomy Understanding NICE guidance information for people considering the procedure, and for
More informationNHS Greater Glasgow and Clyde Yorkhill Hospital CONSTIPATION IN CHILDREN
NHS Greater Glasgow and Clyde Yorkhill Hospital CONSTIPATION IN CHILDREN Constipation in Children Version: 1 Page 1 of 8 Background Constipation is a common complaint in infants and children. The aetiology
More informationTuesday, July 23, 2013. Karen Hanson, RN, CNP Nurse Practitioner, Division of Gastroenterology and Hepatology Mayo Clinic, Rochester, MN
Tuesday, July 23, 2013 Speakers Karen Hanson, RN, CNP Nurse Practitioner, Division of Gastroenterology and Hepatology Mayo Clinic, Rochester, MN Susanne Benouna Medical Secretary, Division of Gastroenterology
More informationInformation for Patients having a Colonic Stent Placement
Information for Patients having a Colonic Stent Placement Information for Patients having a Colonic Stent Placement The Digestive System To understand the procedure you are about to have, it helps to have
More informationAcute abdominal conditions Key Points
7 Acute abdominal conditions Key Points 7.1 ASSESSMENT AND DIAGNOSIS Referred abdominal pain Fore gut pain (stomach, duodenum, gall bladder) is referred to the upper abdomen Mid gut pain (small intestine,
More informationClinical Implementation of. Pharmacist-Managed Service. Kristine R. Crews, Pharm.D., BCPS St. Jude Children s Research Hospital
Clinical Implementation of Pharmacogenomics Through a Pharmacist-Managed Service Kristine R. Crews, Pharm.D., BCPS St. Jude Children s Research Hospital Objectives 1. Describe steps for incorporating pharmacogenomic
More informationTreatment of diseases affecting the kidney using steroids
Treatment of diseases affecting the kidney using steroids Hope Building Renal 0161 206 5223 All Rights Reserved 2015. Document for issue as handout. This information has been written by the medical and
More informationRecommendations for Early RA Patients
SUPPLEMENTARY APPENDIX 5: Executive summary of recommendations for patients with early RA, established RA, and high-risk comorbidities Recommendations for Early RA Patients We strongly recommend using
More informationColorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society
Colorectal Cancer: Preventable, Beatable, Treatable American Cancer Society Reviewed January 2016 What we ll be talking about How common is colorectal cancer? What is colorectal cancer? What causes it?
More informationCholangiocarcinoma (Bile Duct Cancer) Patient Information Booklet
Cholangiocarcinoma (Bile Duct Cancer) Patient Information Booklet Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationDrug Treatment Information for patients with Inflammatory Bowel Disease. Infliximab
Drug Treatment Information for patients with Inflammatory Bowel Disease Infliximab Improving life for people affected by Colitis and Crohn s Disease National Association For Colitis and Crohn s Disease
More informationColon Cancer. What Is Colon Cancer? What Are the Screening Methods?
Cancer of the colon or rectum (colorectal cancer) is the second most common cancer in the U.S. In fact, of all people born, 1 in 40 will die of the disease. What Is Colon Cancer? Colon cancer begins with
More informationCOLORECTAL CANCER SCREENING
COLORECTAL CANCER SCREENING By Douglas K. Rex, M.D., FACG & Suthat Liangpunsakul, M.D. Division of Gastroenterology and Hepatology, Department of Medicine Indiana University School of Medicine Indianapolis,
More informationIndication: Indication: Protaxos is indicated in adults.
Maklumat tambahan indikasi untuk upload pada laman web Year 2013 Products Approved For Additional Indication (DCA 262 28 Mac 2013) NO PRODUCT (ACTIVE INGREDIENT) 1. 1.1 EVISTA TABLET 60MG [ Raloxifene
More informationYALE UNIVERSITY SCHOOL OF MEDICINE: SECTION OF OTOLARYNGOLOGY PATIENT INFORMATION FUNCTIONAL ENDOSCOPIC SINUS SURGERY
YALE UNIVERSITY SCHOOL OF MEDICINE: SECTION OF OTOLARYNGOLOGY PATIENT INFORMATION FUNCTIONAL ENDOSCOPIC SINUS SURGERY What is functional endoscopic sinus surgery (FESS)? Functional endoscopic sinus surgery
More informationProfessor Andrew Wright,
Professor Andrew Wright, Systemic treatments are drugs taken as tablets or injections that travel through the bloodstream, dampening down the immune system to reach and treat eczema all over the body.
More informationRelapsing remitting MS
An introduction to Relapsing remitting MS What does it mean when you are diagnosed with relapsing remitting MS? There are three main types of MS: relapsing remitting MS, primary progressive MS and secondary
More informationMEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES I. Requirements for Prior Authorization of Tysabri
MEDICAL ASSISTANCE HBOOK PRI AUTHIZATION OF I. Requirements for Prior Authorization of Tysabri A. Prescriptions That Require Prior Authorization All prescriptions for Tysabri must be prior authorized.
More informationLambeth and Southwark Action on Malnutrition Project (LAMP) Dr Liz Weekes Project Lead Guy s & St Thomas NHS Foundation Trust
Lambeth and Southwark Action on Malnutrition Project (LAMP) Dr Liz Weekes Project Lead Guy s & St Thomas NHS Foundation Trust Page 0 What is the problem? Page 1 3 million (5 % population) at risk of malnutrition
More informationGuidance on adverse drug reactions
Guidance on adverse drug reactions Classification of adverse drug reactions Adverse drug reactions are frequently classified as type A and type B reactions. An extended version of this classification system
More informationProblems of the Digestive System
The American College of Obstetricians and Gynecologists f AQ FREQUENTLY ASKED QUESTIONS FAQ120 WOMEN S HEALTH Problems of the Digestive System What are some common digestive problems? What is constipation?
More informationX-ray (Radiography), Lower GI Tract
Scan for mobile link. X-ray (Radiography), Lower GI Tract What is Lower GI Tract X-ray Radiography (Barium Enema)? Lower gastrointestinal (GI) tract radiography, also called a lower GI or barium enema,
More informationA guide for adults with. Intestinal. Dysmotility
A guide for adults with Intestinal Dysmotility This leaflet contains information for patients with dysmotility of the gut and discusses symptoms and management. page 2 Contents Introduction 4 Symptoms
More informationChapter 6 Gastrointestinal Impairment
Chapter 6 Gastrointestinal This chapter consists of 2 parts: Part 6.1 Diseases of the digestive system Part 6.2 Abdominal wall hernias and obesity PART 6.1: DISEASES OF THE DIGESTIVE SYSTEM Diseases of
More information